Home › Compare › VYYRF vs EQR

VYYRF vs EQR: Dividend Comparison 2026

VYYRF yields 2272.73% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VYYRF wins by $32854240502.56M in total portfolio value
10 years
VYYRF
VYYRF
● Live price
2272.73%
Share price
$0.09
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$32854240502.61M
Annual income
$30,237,080,305,789,680.00
Full VYYRF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — VYYRF vs EQR

📍 VYYRF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVYYRFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VYYRF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
VYYRF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VYYRF
Annual income on $10K today (after 15% tax)
$193,181.82/yr
After 10yr DRIP, annual income (after tax)
$25,701,518,259,921,228.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, VYYRF beats the other by $25,701,518,259,916,572.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VYYRF + EQR for your $10,000?

VYYRF: 50%EQR: 50%
100% EQR50/50100% VYYRF
Portfolio after 10yr
$16427120251.33M
Annual income
$15,118,540,152,897,578.00/yr
Blended yield
92.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

VYYRF
No analyst data
Altman Z
-3.6
Piotroski
4/9
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VYYRF buys
0
EQR buys
0
No recent congressional trades found for VYYRF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVYYRFEQR
Forward yield2272.73% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$32854240502.61M ✓$47.8K
Annual income after 10y$30,237,080,305,789,680.00 ✓$5,475.61
Total dividends collected$32670211031.59M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: VYYRF vs EQR ($10,000, DRIP)

YearVYYRF PortfolioVYYRF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$237,973$227,272.73$11,380$679.82+$226.6K → VYYRF
2$5,309,277$5,054,645.86$13,014$837.25+$5.30M → VYYRF
3$111,074,741$105,393,815.30$14,961$1,036.20+$111.06M → VYYRF
4$2,179,533,508$2,060,683,535.02$17,297$1,289.22+$2179.52M → VYYRF
5$40,122,002,626$37,789,901,771.73$20,121$1,613.15+$40121.98M → VYYRF
6$693,076,755,656$650,146,212,846.56$23,561$2,030.84+$693076.73M → VYYRF
7$11,237,644,552,173$10,496,052,423,620.71$27,783$2,573.54+$11237644.52M → VYYRF
8$171,075,194,313,012$159,050,914,642,187.34$33,013$3,284.39+$171075194.28M → VYYRF
9$2,445,944,109,174,152$2,262,893,651,259,228.50$39,547$4,223.51+$2445944109.13M → VYYRF
10$32,854,240,502,606,024$30,237,080,305,789,680.00$47,791$5,475.61+$32854240502.56M → VYYRF

VYYRF vs EQR: Complete Analysis 2026

VYYRF — Stock

Voyageur Pharmaceuticals Ltd. focuses on the development of active pharmaceutical ingredients minerals. The company intends to develop barium and iodine radiocontrast products and bromine based pharmaceutical products. It holds 100% interest in three barium sulfate deposits, including two properties suitable in grade for the pharmaceutical barite marketplace located in British Columbia, Canada; and interests in a high-grade iodine, lithium, and bromine brine project in Utah, the United States. The company was formerly known as Voyageur Minerals Ltd. and changed its name to Voyageur Pharmaceuticals Ltd. in December 2019. Voyageur Pharmaceuticals Ltd. is headquartered in Calgary, Canada.

Full VYYRF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this VYYRF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VYYRF vs SCHDVYYRF vs JEPIVYYRF vs OVYYRF vs KOVYYRF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.